A squalene-based nanocomposite containing a drug that disrupts blood vessel growth and an anticancer agent could help more efficiently treat tumours, say researchers in France. The treatment has already been tested on mice bearing human colon cancer cells and appears to cause tumours to regress by as much as 93%………
http://nanotechweb.org/cws/article/tech/56536
